Clinical Trial Update: TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir ("TMC114/r") in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications. [Phase 3]

View source ↗

Summary

A Phase 3 trial of the investigational protease inhibitor TMC114 (darunavir) with ritonavir in HIV-1 infected patients who have never received antiretroviral th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Norvir (ritonavir)
• PREZISTA (darunavir)

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: HIV | Phase 3 | Status: COMPLETED